Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_1824222
Proper Citation: LSBio (LifeSpan) Cat# LS-C87898-100, RRID:AB_1824222
Target Antigen: E. coli Tumor Protein P53 (Li-Fraumeni Syndrome) (TP53)
Host Organism: mouse
Clonality: monoclonal
Comments: vendor suggested use: Flow Cytometry; Gel Shift; Immunofluorescence; Immunohistochemistry; Immunoprecipitation; Western Blot; Flow Cytometry, Gel Shift, Immunofluorescence, Immunohistochemistry (Parrafin) (1 - 2 ??g/ml), Immunoprecipitation, Western Blot (1 - 2 ??g/ml)
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Mouse Anti-E. coli Tumor Protein P53 (Li-Fraumeni Syndrome) (TP53) Monoclonal, Azide-free Conjugated, Clone Do-1.
No alerts have been found for Mouse Anti-E. coli Tumor Protein P53 (Li-Fraumeni Syndrome) (TP53) Monoclonal, Azide-free Conjugated, Clone Do-1.
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.